🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
541 medicines starting with “R”
MedicineActive substanceLicence holderStatus
Rispeva 4 mg film-coated tablets
PA0749/049/010
Risperidone Teva Pharma B.V. Marketed
Rispone 0.5 mg film-coated tablets
PA0711/106/002
Risperidone Rowex Limited, Marketed
Rispone 1 mg film-coated tablets
PA0711/106/006
Risperidone Rowex Limited, Marketed
Rispone 1 mg/ml oral solution
PA0711/106/001
Risperidone Rowex Limited, Marketed
Rispone 2 mg film-coated tablets
PA0711/106/007
Risperidone Rowex Limited, Marketed
Rispone 3 mg film-coated tablets
PA0711/106/008
Risperidone Rowex Limited, Marketed
Ristaben 100 mg film-coated tablets
EU/1/10/621/13-18
Sitagliptin as monohydrate phosphate salt Merck Sharp & Dohme BV,
Ristaben 25 mg film-coated tablets
EU/1/10/621/1-6
Sitagliptin as monohydrate phosphate salt Merck Sharp & Dohme BV
Ristaben 50 mg film-coated tablets
EU/1/10/621/7-12
Sitagliptin as monohydrate phosphate salt Merck Sharp & Dohme BV,
Ristfor 50 mg/1000 mg film-coated tablets
EU/1/10/620/009-016
Metformin Hydrochloride, Sitagliptin phosphate Merck Sharp & Dohme BV,
Ristfor 50 mg/850 mg film-coated tablets
EU/1/10/620/1-8
Metformin Hydrochloride, Sitagliptin phosphate Merck Sharp & Dohme BV
Ritalin 10mg Tablets
PA1972/002/001
Methylphenidate hydrochloride InfectoPharm Arzneimittel und Consilium GmbH Marketed
Ritalin LA 20mg prolonged-release capsules
PA1972/002/002
Methylphenidate hydrochloride InfectoPharm Arzneimittel und Consilium GmbH Marketed
Ritalin LA 30mg prolonged-release capsules
PA1972/002/003
Methylphenidate hydrochloride InfectoPharm Arzneimittel und Consilium GmbH Marketed
Ritalin LA 40mg prolonged-release capsules
PA1972/002/004
Methylphenidate hydrochloride InfectoPharm Arzneimittel und Consilium GmbH Marketed
Ritonavir Viatris 100 mg Film-coated tablet
EU/1/17/1242/001-003
Ritonavir Viatris Limited
RIULVY 174 mg gastro-resistant hard capsules
EU/1/25/1947/001-002
Tegomil fumarate Neuraxpharm Pharmaceuticals S.L.
RIULVY 348 mg gastro-resistant hard capsules
EU/1/25/1947/003-005
Tegomil fumarate Neuraxpharm Pharmaceuticals S.L.
Rivaroxaban 10 mg film-coated tablets
PA22865/010/001
Rivaroxaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Rivaroxaban 15 mg film-coated tablets
PA22865/010/002
Rivaroxaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Rivaroxaban 20 mg film-coated tablets
PA22865/010/003
Rivaroxaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Rivaroxaban Accord 10 mg film-coated tablets
EU/1/20/1488/012-023
Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Accord 15 mg film-coated tablets
EU/1/20/1488/024-038
Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Accord 15 mg film-coated tablets Rivaroxaban Accord 20 mg film-coated tablets
EU/1/20/1488/039
Rivaroxaban, Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Accord 2.5 mg film-coated tablets
EU/1/20/1488/001-011
Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Accord 20 mg film-coated tablets
EU/1/20/1488/040-053
Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Ascend 10 mg film-coated tablets
PA23429/007/002
Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Ascend 15 mg film-coated tablets
PA23429/007/003
Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Ascend 15 mg film-coated tablets Rivaroxaban Ascend 20 mg film-coated tablets
PA23429/007/005
Rivaroxaban, Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Ascend 2.5 mg film-coated tablets
PA23429/007/001
Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Ascend 20 mg film-coated tablets
PA23429/007/004
Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Azure 10 mg film-coated tablets
PA1963/019/002
Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Azure 15 mg film-coated tablets
PA1963/019/003
Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Azure 15 mg film-coated tablets Rivaroxaban Azure 20 mg film-coated tablets
PA1963/019/005
Rivaroxaban, Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Azure 2.5 mg film-coated tablets
PA1963/019/001
Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Azure 20 mg film-coated tablets
PA1963/019/004
Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Bluefish 10 mg film-coated tablets
PA1436/044/001
Rivaroxaban Bluefish Pharmaceuticals AB Not marketed
Rivaroxaban Bluefish 15 mg film-coated tablets
PA1436/044/002
Rivaroxaban Bluefish Pharmaceuticals AB Not marketed
Rivaroxaban Bluefish 15 mg film-coated tablets Rivaroxaban Bluefish 20 mg film-coated tablets
PA1436/044/004
Rivaroxaban, Rivaroxaban Bluefish Pharmaceuticals AB Not marketed
Rivaroxaban Bluefish 20 mg film-coated tablets
PA1436/044/003
Rivaroxaban Bluefish Pharmaceuticals AB Not marketed
Rivaroxaban Clonmel 10 mg film-coated tablets
PA0126/035/002
Rivaroxaban Clonmel Healthcare Ltd Not marketed
Rivaroxaban Clonmel 15 mg film-coated tablets
PA0126/035/003
Rivaroxaban Clonmel Healthcare Ltd Marketed
Rivaroxaban Clonmel 15 mg film-coated tablets Rivaroxaban Clonmel 20 mg film-coated tablets
PA0126/035/005
Rivaroxaban, Rivaroxaban Clonmel Healthcare Ltd Not marketed
Rivaroxaban Clonmel 2.5 mg film-coated tablets
PA0126/035/001
Rivaroxaban Clonmel Healthcare Ltd Not marketed
Rivaroxaban Clonmel 20 mg film-coated tablets
PA0126/035/004
Rivaroxaban Clonmel Healthcare Ltd Marketed
Rivaroxaban Grindeks 10 mg film-coated tablets
PA22992/008/001
Rivaroxaban AS Grindeks Not marketed
Rivaroxaban Grindeks 15 mg film-coated tablets
PA22992/008/002
Rivaroxaban AS Grindeks Not marketed
Rivaroxaban Grindeks 20 mg film-coated tablets
PA22992/008/003
Rivaroxaban AS Grindeks Not marketed
Rivaroxaban Krka 10 mg film-coated tablets
PA1347/098/002
Rivaroxaban KRKA, d.d., Novo mesto Marketed
Rivaroxaban Krka 15 mg film-coated tablets
PA1347/098/003
Rivaroxaban KRKA, d.d., Novo mesto Marketed
4 5 6 7 8 9 10

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.